T1	Participants 22 125	finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
T2	Participants 137 258	Male pseudohermaphrodites (MPHs) with inherited 5 alpha-reductase deficiency and decreased dihydrotestosterone production
T3	Participants 634 748	The 5 alpha-steroid metabolite profile in the MPHs was compared with that of men with benign prostatic hyperplasia
